Collegium Pharmaceutical (COLL) Total Liabilities (2014 - 2026)

Collegium Pharmaceutical's Total Liabilities history runs 13 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Total Liabilities fell 4.11% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (down 4.11% YoY), while the FY2025 annual figure was $1.4 billion, down 5.55% from the prior year.
• Total Liabilities was $1.3 billion for Q1 2026 at Collegium Pharmaceutical, down from $1.4 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.4 billion in Q4 2024 to a low of $836.8 million in Q2 2024.
• Historically, Total Liabilities has averaged $1.1 billion across 5 years, with a median of $1.0 billion in 2022.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities jumped 127.49% in 2022, then retreated 17.4% in 2024.
• A 5-year view of Total Liabilities shows it stood at $979.3 million in 2022, then declined by 3.21% to $947.9 million in 2023, then soared by 51.36% to $1.4 billion in 2024, then slipped by 5.55% to $1.4 billion in 2025, then slipped by 1.15% to $1.3 billion in 2026.
• The last three Total Liabilities figures came in at $1.3 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.